Gregory Cole Davis serves as Executive at BIOANALYTICAL SYSTEMS INC, where they oversee executive responsibilities. Since joining the company, Gregory Cole Davis has executed 11 insider transactions totaling $150.2K, demonstrating a bullish approach to their equity position. Their most recent transaction on Apr 1, 2023 involved receiving (via award) 25,822 shares valued at $0.
Gregory Cole Davis currently holds 67,780 shares of BIOANALYTICAL SYSTEMS INC (BASI), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Gregory Cole Davis has been a net buyer of BASI stock. They have purchased $150.2K and sold $0 worth of shares.
Gregory Cole Davis's most recent insider trade was on Apr 1, 2023, when they sold 25,822 shares at $0.00 per share.
Get notified when new Form 4 filings are submitted
| $N/A |
| Discretionary |
| Feb 18, 2022 | NOTV | $59.8K | Purchase | 2,500 | $23.93 | Discretionary |
| Feb 18, 2022 | NOTV | $26.4K | Purchase | 1,250 | $21.12 | Discretionary |
| Feb 17, 2022 | NOTV | $25.7K | Purchase | 1,250 | $20.57 | Discretionary |
| Apr 1, 2021 | NOTV | $0 | Award | 2,683 | $N/A | Discretionary |
| Apr 1, 2020 | BASI | $0 | Award | 10,000 | $N/A | Discretionary |
| May 31, 2019 | BASI | $10.0K | Purchase | 5,000 | $2.00 | Discretionary |
| May 30, 2019 | BASI | $9.8K | Purchase | 5,000 | $1.96 | Discretionary |
| May 29, 2019 | BASI | $9.9K | Purchase | 5,000 | $1.99 | Discretionary |
| Aug 18, 2017 | BASI | $8.5K | Purchase | 5,000 | $1.70 | Discretionary |